The BH3-only protein NOXA serves as an independent predictor of breast cancer patient survival and defines susceptibility to microtubule targeting agents
G. Karbon, M. D. Haschka, H. Hackl, C. Soratroi, L. Rocamora-Reverte, W. Parson, H. Fiegl, A. Villunger
This study identifies NOXA as an independent prognostic marker for breast cancer survival and shows its role in predicting response to microtubule-targeting agents.
bioRxiv · May 26, 2021Cancer Biology